{
    "clinical_study": {
        "@rank": "151528", 
        "arm_group": [
            {
                "arm_group_label": "Sequence 1", 
                "arm_group_type": "Experimental", 
                "description": "amosartan \u2192 rosuvastatin \u2192  amosartan and rosuvastatin"
            }, 
            {
                "arm_group_label": "Sequence 2", 
                "arm_group_type": "Experimental", 
                "description": "rosuvastatin \u2192 amosartan and rosuvastatin \u2192  amosartan"
            }, 
            {
                "arm_group_label": "Sequence 3", 
                "arm_group_type": "Experimental", 
                "description": "amosartan and rosuvastatin \u2192  amosartan \u2192 rosuvastatin"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the drug-drug interaction between\n      amlodipine/losartan and rosuvastatin in healthy male volunteers."
        }, 
        "brief_title": "Evaluating a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy male\n\n          -  Age between 19 and 55\n\n          -  Signed informed consent\n\n        Exclusion Criteria:\n\n          -  Presence of medical history or a concurrent disease\n\n          -  Has a history of hypersensitivity to IP ingredients"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 9, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02140489", 
            "org_study_id": "HM-ALRO-101"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Sequence 1", 
                    "Sequence 2", 
                    "Sequence 3"
                ], 
                "intervention_name": "amosartan", 
                "intervention_type": "Drug", 
                "other_name": "amosartan, P.O"
            }, 
            {
                "arm_group_label": [
                    "Sequence 1", 
                    "Sequence 2", 
                    "Sequence 3"
                ], 
                "intervention_name": "rosuvastatin", 
                "intervention_type": "Drug", 
                "other_name": "rosuvastatin, P.O"
            }, 
            {
                "arm_group_label": [
                    "Sequence 1", 
                    "Sequence 2", 
                    "Sequence 3"
                ], 
                "intervention_name": "amosartan and rosuvastatin", 
                "intervention_type": "Drug", 
                "other_name": "amosartan and rosuvastatin, P.O"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Amlodipine", 
                "Losartan", 
                "Rosuvastatin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 15, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Samgsung Seoul Hospital"
            }, 
            "investigator": {
                "last_name": "JaeWook Ko, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "3", 
        "official_title": "An Open-label, Randomized, Single-dose Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin in Healthy Male Volunteers", 
        "overall_contact": {
            "email": "jajung@hanmi.co.kr", 
            "last_name": "Jin-A Jung, Ph.D"
        }, 
        "overall_official": {
            "affiliation": "Samsung Seoul Hospital", 
            "last_name": "JaeWook Ko, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Ministry of Food and Drug Safety", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Cmax", 
                "safety_issue": "No", 
                "time_frame": "0-72h"
            }, 
            {
                "measure": "AUClast", 
                "safety_issue": "No", 
                "time_frame": "0-72h"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02140489"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "tmax", 
                "safety_issue": "No", 
                "time_frame": "0-72h"
            }, 
            {
                "measure": "t1/2", 
                "safety_issue": "No", 
                "time_frame": "0-72h"
            }, 
            {
                "measure": "AUCinf", 
                "safety_issue": "No", 
                "time_frame": "0-72h"
            }
        ], 
        "source": "Hanmi Pharmaceutical Company Limited", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hanmi Pharmaceutical Company Limited", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}